Home | Business News | Browse by Publication | P | PR Newswire

Gliadel(R) Wafer Clinical Data Presented at Society for Neuro-Oncology Meeting.

Publication: PR Newswire
Publication Date: 20-NOV-06 		Format: Online
Delivery: Immediate Online Access

Article Excerpt
ORLANDO, Fla., Nov. 20 /PRNewswire-FirstCall/ -- MGI PHARMA, INC. , a biopharmaceutical company focused in oncology and acute care, today summarized interim results from a phase 2 combination study of Gliadel(R) Wafer (polifeprosan 20 with carmustine implant) in patients with newly-diagnosed, resectable, high grade malignant gliomas presented at the 2006 Society for Neuro-Oncology (SNO) Annual Meeting. Interim data from 35 patients with this aggressive brain tumor showed a median survival of 18.6 months when Gliadel Wafer and temozolomide are used in combination with surgery and radiotherapy.

"Although preliminary, these data are intriguing and warrant additional clinical investigation," commented Renato LaRocca, M.D., Principal Investigator of the study and Director of the Kentuckiana Cancer Institute. "By using quadruple-modality therapy, we may be having an impact on select patients with this devastating tumor. With each new study in brain tumors, we gain further insight into the appropriate sequencing of novel treatment combinations."

About the Study

This phase...

Read the FULL article now - Try Goliath Business News - FREE!   
You can view this article PLUS...

  • Over 5 million business articles
  • Hundreds of the most trusted magazines, newswires, and journals (see list)
  • Premium business information that is timely and relevant
  • Unlimited Access

Now for a Limited Time, try Goliath Business News - Free for 3 Days!
Tell Me More   Terms and Conditions

Get Goliath Business News for 1 year - Just $99 (Save 65%)
Tell Me More   Terms and Conditions

Already a subscriber? Log in to view full article



More articles from PR Newswire
American Woodmark Authorizes $50 Million Stock Repurchase., November 20, 2006
Lowe's Reports Record Third Quarter Earnings., November 20, 2006
Pinnacle Entertainment Increases Credit Facility to $1 Billion., November 20, 2006
Allos Therapeutics Added to NASDAQ Biotech Index., November 20, 2006
Systemax Partners With 8x8, Inc. to Bring VoIP to the Masses., November 20, 2006

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.